Intestinal Models for Personalized Medicine: from Conventional Models to Microfluidic Primary Intestine-on-a-chip.
Intestinal Models for Personalized Medicine: from Conventional Models to Microfluidic Primary Intestine-on-a-chip.
复制标题
DOI:
10.1007/s12015-021-10205-y
复制
发表时间:
2022-08
影响因子:
4.8
通讯作者:
Wang XQ
中科院分区:
文献类型:
--
作者:
Li XG;Chen MX;Zhao SQ;Wang XQ
Intestinal dysfunction is frequently driven by abnormalities of specific genes, microbiota, or microenvironmental factors, which usually differ across individuals, as do intestinal physiology and pathology. Therefore, it’s necessary to develop personalized therapeutic strategies, which are currently limited by the lack of a simulated intestine model. The mature human intestinal mucosa is covered by a single layer of columnar epithelial cells that are derived from intestinal stem cells (ISCs). The complexity of the organ dramatically increases the difficulty of faithfully mimicking in vivo microenvironments. However, a simulated intestine model will serve as an indispensable foundation for personalized drug screening. In this article, we review the advantages and disadvantages of conventional 2-dimensional models, intestinal organoid models, and current microfluidic intestine-on-a-chip (IOAC) models. The main technological strategies are summarized, and an advanced microfluidic primary IOAC model is proposed for personalized intestinal medicine. In this model, primary ISCs and the microbiome are isolated from individuals and co-cultured in a multi-channel microfluidic chip to establish a microengineered intestine device. The device can faithfully simulate in vivo fluidic flow, peristalsis-like motions, host-microbe crosstalk, and multi-cell type interactions. Moreover, the ISCs can be genetically edited before seeding, and monitoring sensors and post-analysis abilities can also be incorporated into the device to achieve high-throughput and rapid pharmaceutical studies. We also discuss the potential future applications and challenges of the microfluidic platform. The development of cell biology, biomaterials, and tissue engineering will drive the advancement of the simulated intestine, making a significant contribution to personalized medicine in the future. The intestine is a primary organ for digestion, absorption, and metabolism, as well as a major site for the host-commensal microbiota interaction and mucosal immunity. The complexity of the organ dramatically increases the difficulty of faithfully mimicking in vivo microenvironments, though physiological 3-dimensional of the native small intestinal epithelial tissue has been well documented. An intestinal stem cells-based microfluidic intestine-on-a-chip model that faithfully simulate in vivo fluidic flow, peristalsis-like motions, host-microbe crosstalk, and multi-cell type interactions will make a significant contribution.
登录
查看更多内容
影响因子:
3.6
作者:
Derricott H;Luu L;Fong WY;Hartley CS;Johnston LJ;Armstrong SD;Randle N;Duckworth CA;Campbell BJ;Wastling JM;Coombes JL
通讯作者:
Coombes JL
影响因子:
64.8
作者:
Ayyaz, Arshad;Kumar, Sandeep;Gregorieff, Alex
通讯作者:
Gregorieff, Alex
影响因子:
46.9
作者:
Bhatia, Sangeeta N.;Ingber, Donald E.
通讯作者:
Ingber, Donald E.
影响因子:
8.8
作者:
Co, Julia Y.;Margalef-Catala, Mar;Amieva, Manuel R.
通讯作者:
Amieva, Manuel R.
DOI:
10.1016/j.jcmgh.2017.12.010
发表时间:
2018
影响因子:
7.2
作者:
Bein A;Shin W;Jalili-Firoozinezhad S;Park MH;Sontheimer-Phelps A;Tovaglieri A;Chalkiadaki A;Kim HJ;Ingber DE
通讯作者:
Ingber DE